Chiesi, an international research-focused biopharmaceutical group, has earned the EcoVadis Platinum Medal for the second time, placing it among the top 1% of companies assessed by EcoVadis worldwide.
They have a strong commitment to excellence in environmental, social, and ethical practices.
In 2024, Chiesi maintained its Platinum status and improved its overall score by 5 points, underlining the Group’s dedication to global health crisis issues.
According to the filing, this achievement reflects the company’s efforts to integrate sustainable practices into every aspect of its operations, emphasising its role as a Benefit Corporation and a certified B Corp.
Chiesi is a leader.
The EcoVadis Platinum Medal award indicates the company’s leadership and commitment to driving positive change in the pharma industry.
Cecilia Plicco, Head of Shared Value & Sustainability, said: “Sustainability lies at the core of everything we do at Chiesi.
Our commitment to shaping a collaborative value chain aligns with our overarching goals: improving patients’ quality of life, protecting the planet’s health, and supporting the development of the communities where we operate.
Guido D’Agostino, Head of Global Procurement, highlighted the value of partnerships: “Working in partnership within our ecosystem is key in addressing critical global challenges like climate change and human rights.
It is a reflection of our collective efforts and shared vision.
EcoVadis is a globally recognised platform that assesses the sustainability performance of companies across various sectors.
For more information on EcoVadis and its ratings, you can visit the EcoVadis website.
The EcoVadis Platinum Medal
The EcoVadis Platinum Medal is the highest accolade, awarded to the top 1% of companies, signifying exceptional commitment to sustainable practices and leadership in corporate social responsibility.
Companies are evaluated and scored from 0 to 100, with achievements recognised through medals and badges, focusing on environmental performance, labour and human rights, ethics, and sustainable procurement.
EcoVadis assessment
The assessment process involves a thorough evaluation of a company’s sustainability performance, with a focus on 21 criteria.
Chiesi’s strong commitment to sustainability has earned it a place among the top 1% of companies assessed by EcoVadis, with a 5-point improvement in its overall score.
Commitment to sustainability
Chiesi’s commitment to sustainability is reflected in its role as a Benefit Corporation and a certified B Corp, and its overarching goals include improving patients’ quality of life, protecting the planet’s health.
With its strong commitment to sustainability, Chiesi is driving positive change in the pharma industry.
Sustainable business practices are becoming increasingly important for companies.
As the company continues to prioritise sustainability, the pharma industry is likely to become more sustainable and responsible, much like the research on heart artery plaques has shown.
Related: Neutrophils produce protein linked to schizophrenia
Leave a Reply